Large Series B Rounds Lead the Day
The biggest checks of the day went to enterprise software and AI imaging platforms, signaling continued investor appetite for automation and data-driven tools.
- Freehand: $75M Series B, focused on autonomous AI agents that manage supply chain spend and back-office operations for Fortune 500 companies. No lead investor was disclosed in available reports.
- Qureight: $20M Series B, for its AI-powered imaging platform serving clinical trials with a focus on lung and heart disease. No lead investor was named in available reports.
Series A: Enterprise Sales and AI Infrastructure
Two Series A rounds highlighted the demand for AI-driven go-to-market and product tooling.
- Centralize: $15M Series A, founded by former Meta and Slack engineers, building what the company calls a "deal GPS" for enterprise sales teams. The round was disclosed exclusively to Crunchbase News.
- Revspot: $4.8M Series A, an AI startup planning to use the funds to improve its product and engineering capabilities, expand into new B2C sectors, and grow internationally. No lead investor was named in available reports.
Preventive Health and Clinical Innovation
Health remained a strong theme, with capital flowing into both consumer prevention and clinical research infrastructure.
- Ahead Health: approximately $10M (€8.7M), led by 3VC and RTP Global, for the Zurich-based preventive healthcare platform, which is simultaneously launching in Germany and the Netherlands.
Electric Mobility and Transportation Tech
Europe's mobility sector attracted both institutional financing and early venture capital.
- Drivalia: €48M in financing from the European Investment Bank, earmarked for deploying nearly 2,900 battery electric vehicles across Italy and Finland. Drivalia is part of the Crédit Agricole Auto Bank group.
- Sigvi: €1.2M pre-seed, led by Helsinki-based Superhero Capital, for the Vilnius-based AI revenue platform serving the car rental industry, with plans to expand across Europe.
Pre-Seed and Early-Stage Raises
Earlier-stage companies also secured capital across robotics and agtech.
- Kinematic Trees: approximately £1M (£585K) pre-seed, for the UK-based robotics software startup developing a robot-agnostic motion planning platform inspired by natural movement.
Fund Launches and Acquisitions
Beyond individual rounds, two notable structural moves rounded out the day.
- Anicut Capital launched the Grand Anicut Seed Fund, targeting Rs 175 crore (approximately $21M) to back pre-Series A and Series A startups in deeptech, enterprise technology, consumer businesses, and financial services in India.
- Wild Bio (Wild Bioscience) acquired F1 Seed, a Suffolk-based wheat breeding business, to form what the company describes as Britain's first independent precision-breeding wheat company. Financial terms were not disclosed. The deal follows Wild Bio's previously closed €51M Series A.
What the Day's Raises Signal
July 30 reinforced a few patterns that have been building through mid-2026. Enterprise AI automation, whether in supply chain management, sales workflows, or clinical imaging, continues to attract the largest checks, with investors clearly rewarding companies that can demonstrate direct cost savings for large organizations. Meanwhile, the preventive health and electric mobility sectors are attracting capital at multiple stages simultaneously, from pre-seed to EIB-level institutional financing, suggesting that infrastructure for both consumer wellness and clean transportation is still considered early relative to its eventual scale. The day's activity also underlines that European early-stage startups are being pushed, and funded, to expand internationally sooner than prior generations, a trend that applies directly to Ahead Health and Sigvi.